Laurence W. Lytton Files Schedule 13G Reporting 5% Stake in Codexis, Inc.

Laurence W. Lytton has filed a Schedule 13G with the SEC reporting beneficial ownership of approximately 5% of Codexis, Inc.'s common stock. The filing discloses that Lytton owns 4,532,069 shares of the biotechnology company, representing 5.0% of the outstanding shares based on 90,324,383 shares outstanding as of November 3, 2025. The shares are held with sole voting and dispositive power, and Lytton has certified that the securities were not acquired for the purpose of changing or influencing control of the issuer. The filing was made pursuant to Rule 13d-1(c) and indicates that Lytton is an individual investor. This represents a new position for Lytton, who previously held no shares in Codexis.